Table 2 Baseline VEP parameters from 50 non-diabetic subjects, diabetic patients treated with ozone and controls, by sex
From: Efficacy of ozone therapy on visual evoked potentials in diabetic patients
Group | VEP parameter | Total (mean ± SD) | Males (mean ± SD) | Females (mean ± SD) | P-value |
|---|---|---|---|---|---|
Healthy subjects | P100 wave latency (ms) | 98.83 ± 4.48 | 101.22 ± 4.50 | 96.60 ± 4.45 | 0.002 |
P100 amplitude (μV) | 7.08 ± 2.08 | 6.54 ± 2.02 | 7.67 ± 2.09 | 0.085 | |
Treatment arm | P100 wave latency (ms) | 108.33 ± 5.36 | 111.82 ± 5.37 | 103.76 ± 5.32 | 0.001 |
P100 amplitude (μV) | 4.03 ± 1.89 | 3.98 ± 1.90 | 4.09 ± 1.88 | 0.112 | |
Control arm | P100 wave latency (ms) | 108.31 ± 5.29 | 111.53 ± 5.30 | 104.68 ± 5.22 | 0.001 |
P100 amplitude (μV) | 4.02 ± 1.91 | 3.96 ± 1.91 | 4.08 ± 1.90 | 0.105 |